A phase II randomized, double-blinded, placebo-controlled parallel group trial to examine the efficacy and safety of BI 425809 once daily with adjunctive Computerized Cognitive Training over 12 week treatment periods in patients with schizophrenia.

Project: Research

Project Details

StatusActive
Effective start/end date1/12/20 → 31/12/23

Keywords

  • Psychiatry
  • Schizophrenia
  • Clinical trial